Results 191 to 200 of about 8,780,344 (351)

British Elbow Shoulder Society patient care pathway: Subacromial pain. [PDF]

Shoulder Elbow
Pandey RA, Singh HP, BESS Subacromial Pain Working Group.   +2 more
europepmc   +1 more source

A New Morphological Dataset Reveals a Novel Relationship for the Adzebills of New Zealand (Aptornis) and Provides a Foundation for Total Evidence Neoavian Phylogenetics

, 2019
Grace Musser, Joël Cracraft
openalex   +2 more sources

P223 Update of the british occupational health foundation (bohrf) evidence-based guidelines on the prevention and management of occupational asthma [PDF]

, 2017
Sara De Matteis, Johanna Feary, J Macfarlane, Diane Romano-Woodward, Joanna Szram, GI Walters, Ruth Wiggans, Paul Cullinan   +7 more
openalex   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

Molecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone, James Dunford, Eleanor Calcutt, Vicki Gamble, Filiz Senbabaoglu Aksu, Lorena Ligammari, Georgina Wherry, Giorgia Gaeta, John C. Christianson, Adrienne M. Flanagan, Udo Oppermann, Adam P. Cribbs   +11 more
wiley   +1 more source

Renal resistive index for early prediction of acute kidney injury in sub-Saharan Africa: a scoping review protocol. [PDF]

BMJ Open
Mrara B, Ogbodu OM, Oladimeji O.
europepmc   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Identification of Mitochondria-Related Genes Associated with Stroke Risk Through Multi-omics Summary Data-Based MR Analysis. [PDF]

Mol Neurobiol
Tang X, Cheng G, Chen S, Yao L, Lu L, Shen C, Feng L, Zhang W, Xu N, Wang L.   +9 more
europepmc   +1 more source

Foundations of Evidence Law

, 2005
openaire   +2 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Using a Strategic Model for Professional Development: The Importance of Evidence-Based Competencies as a Foundation for Professional Practice.

, 2015
Peggi Banahan Winter
openalex   +1 more source